FDA Guidance for Industry: Benefit-Risk Considerations for Product Quality Assessments
Title:
FDA Guidance for Industry: Benefit-Risk Considerations for Product Quality Assessments
Origin/Publisher:
FDA
Content:
This guidance describes the benefit-risk principles applied by FDA when conducting product quality-related assessments of chemistry, manufacturing, and controls (CMC)2 information submitted for FDA assessment